Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

Novo Nordisk, the maker of blockbuster weight loss medication Wegovy, will cut 9,000 jobs amid growing competition in the ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

Investors favor Eli Lilly (LLY), but I argue that Novo (NVO) stock outperforms LLY in almost every aspect while trading at a ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Novo Nordisk will cut 9,000 jobs in a global restructuring, targeting annual savings of $1.26 billion, as it faces ...

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...